Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Accessory Structures of the Skin: Hair Growth and Types

Accessory Structures of the Skin: Hair Growth and Types

Hair growth begins with the production of keratinocytes by the basal cells of the hair bulb. As new cells are deposited at the hair bulb, the hair shaft is pushed through the follicle toward the surface. Keratinization is completed as the cells are pushed to the skin surface to form the shaft of hair that is externally visible. The external hair is completely dead and composed entirely of keratin. Hair can be cut or shaven without damaging the hair structure because the cut is superficial. Most...

Treatment Resistent Cancers

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Multipotency and Niche of Bulge Stem Cell

Multipotency and Niche of Bulge Stem Cell

A hair follicle or HF is a small part of the skin that produces the hair shaft. Paul Gerson Unna was the first to observe a bulge in the human hair follicle's outer root sheath (ORS). The bulge is present between the sebaceous gland and the arrector pili muscle and is the niche for hair follicle stem cells (HFSCs). The bulge is also a niche for melanocyte stem cells, and their loss results in graying of hair. The HFSCs express Sox9 and Lhx2, which help them maintain stemness and prevent...

Menopause

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...

Acne Infection

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations.

Frontiers in pharmacology·2026

Same author

You cannot go bald without first losing your hair: telogen effluvium is a precursor to, prerequisite for and potentially an incitant to common baldness in men.

Clinical and experimental dermatology·2025

Same author

Short-term biologic therapy for guttate psoriasis: successful treatment with bimekizumab and literature review.

Clinical and experimental dermatology·2025

Same author

The plasma metabolome of juvenile idiopathic arthritis varies according to subtype and underlying inflammatory status.

Pediatric rheumatology online journal·2024

Same author

Real-world effectiveness and safety of tofacitinib for alopecia areata: A retrospective cohort study of 202 patients.

The Australasian journal of dermatology·2024

Same author

Cross-sectional burden-of-illness study in atopic dermatitis (MEASURE-AD) in Australia and New Zealand reveals impacts on well-being.

The Australasian journal of dermatology·2024

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

Male pattern baldness: current treatments, future prospects.

Justine A Ellis¹, Rodney D Sinclair

¹Department of Physiology, University of Melbourne, Victoria 3010, Australia. justine.ellis@mcri.edu.au

Drug Discovery Today

|July 12, 2008

Summary

Male pattern baldness, a common heritable condition, significantly impacts men

Area of Science:

Dermatology and Genetics
Androgenetic Alopecia Research

Background:

Male pattern baldness (androgenetic alopecia) affects a large proportion of Caucasian men.
This condition can lead to significant psycho-social distress, particularly in younger individuals.
Current treatments offer limited efficacy for managing hair loss.

Purpose of the Study:

To review the current state of male pattern baldness.
To highlight the limitations of existing treatments.
To discuss the potential of emerging therapies and genetic insights.

Main Methods:

Literature review of existing studies on male pattern baldness.
Analysis of current pharmacological treatments and their efficacy.
Exploration of recent advancements in understanding the genetic basis of hair loss.

More Related Videos

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

Related Experiment Videos

Last Updated: Jul 3, 2026

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

A New Technique for Quantitative Analysis of Hair Loss in Mice Using Grayscale Analysis

Published on: March 9, 2015

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Mechanical and Controlled PRP Injections in Patients Affected by Androgenetic Alopecia

Published on: January 27, 2018

Main Results:

Existing treatments for male pattern baldness are not highly effective.
Significant progress is being made in understanding the molecular genetic causes of this condition.
New therapeutic strategies are under development.

Conclusions:

Despite limitations of current options, new treatments for male pattern baldness offer hope.
Advancements in understanding the genetic aetiology will drive future targeted therapies.
Improved management strategies are anticipated for this prevalent condition.